Source: Annual Congress 2009 - Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Nabavi Nouri, M. Rohani, S. J. Mousavi, B. Zamani, H. Yahyazadeh, H. Baradaran (Tehran, Islamic Republic Of Iran). The prevalence of patent foramen ovale in chronic obstructive pulmonary disease patients with increased pulmonary hypertension. Eur Respir J 2009; 34: Suppl. 53, 3849

Member's Comments

No comment yet.

Related content which might interest you: Impact of a patent foramen ovale (PFO) presence in patients with GOLD stage II chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Relevance of persistent foramen ovale in PAH patients on pulmonary vasoactive treatment Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Complex right ventricular response to pulmonary hypertension in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea Source: Eur Respir J 2007; 29: 149-155 Year: 2007 Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 364s Year: 2006 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Chronic obstructive pulmonary disease and pulmonary embolism Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021 The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Echocardiographic evaluation of right ventricular diastolic function in patients with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with cor pulmonale Source: Eur Respir J 2004; 24: Suppl. 48, 112s Year: 2004 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: 782-800 Year: 2007 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010